Related Experiment Video
Updated: Jun 2, 2026

Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark
Published on: January 26, 2018
Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis
1Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Department of Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China.
Abstract:
It is well-documented that the methylation of histone H3 lysine 4 (H3K4) and of H3K9 are mutually exclusive, an epigenetic phenomenon conserved from yeast to humans. How this opposed methylation modification is accomplished and coordinated in mammalian cells is poorly understood. Here we report that the H3K9 trimethyl demethylase JMJD2B is an integral component of the H3K4-specific methyltransferase, the mixed-lineage leukemia (MLL) 2 complex. We show that the JMJD2B/MLL2 complex is copurified with estrogen receptor α (ERα) and is required for ERα-regulated transcription. We demonstrate that H3K9 demethylation and H3K4 methylation are coordinated in ERα-activated transcription such that H3K9 demethylation is a prerequisite for H3K4 methylation. Significantly, depletion of JMJD2B impairs the estrogen-induced G(1)/S transition of the cell cycle in vitro and inhibits breast tumorigenesis in vivo. Interestingly, JMJD2B itself is an ERα target gene, and forms a feed-forward regulatory loop in regulation of the hormone response. Our results provide a molecular basis for the coordinated H3K4 methylation/H3K9 demethylation in transcription activation, link the trimethyl demethylase JMJD2B to euchromatin functions, and provide a mechanism for JMJD2B in breast carcinogenesis.
Insights
The H3K9 demethylase JMJD2B coordinates with the MLL2 complex to regulate estrogen receptor activity. This epigenetic coordination is crucial for cell cycle progression and inhibits breast cancer development.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Research
Background:
- Histone methylation at H3K4 and H3K9 are opposing epigenetic marks.
- The coordination of these marks in mammalian cells remains unclear.
Purpose of the Study:
- To investigate the mechanism coordinating H3K9 demethylation and H3K4 methylation.
- To elucidate the role of JMJD2B in estrogen receptor-regulated transcription and breast cancer.
Main Methods:
- Co-purification assays to identify protein complexes.
- Depletion studies using siRNA to assess gene function.
- Cell cycle analysis and in vivo tumorigenesis models.
Main Results:
- JMJD2B, an H3K9 demethylase, is part of the MLL2 complex, a H3K4 methyltransferase.
- The JMJD2B/MLL2 complex is required for estrogen receptor α (ERα) transcriptional activity.
- H3K9 demethylation precedes H3K4 methylation in ERα-activated transcription.
- JMJD2B depletion inhibits estrogen-induced cell cycle progression and breast tumor growth.
- JMJD2B is an ERα target gene, forming a feed-forward loop.
Conclusions:
- Establishes a molecular mechanism for coordinated H3K4 methylation and H3K9 demethylation in transcription.
- Links JMJD2B to euchromatin regulation and breast carcinogenesis.
- Provides insights into JMJD2B's role in hormone-responsive gene regulation and cancer.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Abnormal Proliferation
Heterochromatin
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at 9th...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...

